Expanding the disease phenotype of ADSSL1-associated myopathy in non-Korean patients.
ADSSL1
Adenylosuccinate synthase
Adult onset distal myopathy
MPD5
Journal
Neuromuscular disorders : NMD
ISSN: 1873-2364
Titre abrégé: Neuromuscul Disord
Pays: England
ID NLM: 9111470
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
02
12
2019
revised:
06
02
2020
accepted:
07
02
2020
pubmed:
26
4
2020
medline:
27
7
2021
entrez:
26
4
2020
Statut:
ppublish
Résumé
Adenylosuccinate synthase (ADSSL1) is a muscle specific enzyme involved in the purine nucleotide cycle and responsible for the conversion of inosine monophosphate to adenosine monophosphate. Since 2016, when mutations in the ADSSL1 gene were first described to be associated with an adult onset distal myopathy, nine patients with compound heterozygous variants in the ADSSL1 gene, all of Korean origin, have been identified. Here we report a novel ADSSL1 mutation and describe two sporadic cases of Turkish and Indian origin. Many of the clinical features of both patients and muscle histopathology and muscle MRI findings, were in accordance with previously reported findings in the adult onset distal myopathy individuals. However, one of our patients presented with progressive, proximally pronounced weakness, severe muscle atrophy and early contractures. Thus, mutations in ADSSL1 have to be considered in patients with both distal and proximal muscle weakness and across various ethnicities.
Identifiants
pubmed: 32331917
pii: S0960-8966(20)30032-8
doi: 10.1016/j.nmd.2020.02.006
pii:
doi:
Substances chimiques
ADSS1 protein, human
EC 6.3.4.4
Adenylosuccinate Synthase
EC 6.3.4.4
Types de publication
Case Reports
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
310-314Subventions
Organisme : NHGRI NIH HHS
ID : UM1 HG008900
Pays : United States
Organisme : NHGRI NIH HHS
ID : R01 HG009141
Pays : United States
Informations de copyright
Copyright © 2020. Published by Elsevier B.V.